Stocktoria

KalVista Pharmaceuticals, Inc. KALV

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-04-09 · LEI

KalVista Pharmaceuticals, Inc. statistics & valuation

Market cap$1.4B
P / B15.1×
Return on equity-192.3%
Return on capital-91.4%

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-711.70% -1485.30% -222.80% -184.90% -319.40% -280.90% 2016201720182019202020212022202320242025
Return on equity (%)
-59.40% -58.00% -21.50% -34.80% -18.00% -44.50% -57.70% -61.30% -192.30% 2016201720182019202020212022202320242025
Shares outstanding
0 9.7M 10.8M 17.3M 17.8M 24.4M 24.6M 34.2M 42.5M 49.8M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-46.20% -54.20% -25.70% -17.60% -31.50% -17.00% -40.40% -50.70% -53.80% -73.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-617.30% -1582.20% 108.80% -232.20% -354.90% -178.50% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$1.64 -$2.42 -$3.36 -$3.33 -$3.44 -$3.69 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin—-280.9%———-319.4%-184.9%-222.8%-1485.3%-711.7%
Net margin—-253.3%———-229.4%-129.1%-188.3%-1236.9%-536.1%
FCF margin—-178.5%———-354.9%-232.2%108.8%-1582.2%-617.3%
Return on assets-73.2%-53.8%-50.7%-40.4%-17.0%-31.5%-17.6%-25.7%-54.2%-46.2%
Return on equity-192.3%-61.3%-57.7%-44.5%-18.0%-34.8%-21.5%-58.0%-59.4%30.8%
Current ratio5.359.9011.4616.7327.0411.496.402.5611.337.59

Computed from company filings · US · as of 2025-04-30. Facts plus Stocktoria's own computed scores — not investment advice.